CD44 and metastatic neoplasm: The upregulation of these two critical ovarian stem-cell markers CD44 and ALDH1L1 in omental metastatic tumors points to a potential interaction between the omental mesothelial cell niche and tumor-derived Notch-Jagged2 signaling in the development of CSC features by tumor cells.